Metabolic Effects of Adjunctive Lumateperone Treatment in Clozapine-Treated people with Schizophrenia
This study is recruiting. It focuses on schizophrenia and currently lists participation information in the United States.
In Worcester
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is recruiting. It focuses on schizophrenia and currently lists participation information in the United States.
In WorcesterThis study is recruiting. It focuses on schizophrenia and currently lists participation information in the Netherlands.
In NetherlandsThis study is recruiting. It focuses on schizophrenia and currently lists participation information in Germany.
In GermanyThis study is recruiting. It focuses on schizophrenia and currently lists participation information in the United Kingdom.
In United KingdomThis study is recruiting. It focuses on schizophrenia and currently lists participation information in Sweden.
In Multiple LocationsThis study is recruiting. It focuses on schizophrenia and currently lists participation information in China.
Multiple locations, including ZhumadianThis study is recruiting. It focuses on schizophrenia and currently lists participation information in China.
Multiple locations, including ChangshaThis study is recruiting. It focuses on schizophrenia and currently lists participation information in the United States.
In Chapel HillThis study is recruiting. It focuses on schizophrenia and currently lists participation information in the United States.
In West Los AngelesThis study is recruiting. It focuses on schizophrenia and currently lists participation information in the United Kingdom.
In United KingdomThis study is recruiting. It focuses on schizophrenia and currently lists participation information in Spain.
In SpainThis study is recruiting. It focuses on schizophrenia and currently lists participation information in the United Kingdom.
In United Kingdom